London, UK, 20 March 2007: BioProgress plc ('BioProgress' or the 'Company')
(AIM: BPRG; NASDAQ: BPRG), the specialty pharmaceutical and healthcare company,
is pleased to announce the creation of a new partnership with Melbrosin Group AG
("Melbrosin"). The Company has also entered into a co-promotion agreement with
Melbrosin for 'Slimthru', a new innovative weight management product which helps
users maintain weight continuity. This product fits strongly with the growing
OTC franchise within BioProgress and the emphasis in niche areas such as
appetite suppressants.
